To stay: Two more cancer indications with ‘dangling approvals’April 29, 2021Genitourinary CancerImmunotherapy
AHA statement flags CV risk of hormonal cancer therapiesApril 29, 2021Mixed TopicsBreast CancerGenitourinary Cancer
Novel BRAF-inhibitor cream ameliorates rash from EGFR inhibitorsApril 29, 2021Gastrointestinal CancerPatient & Survivor Care
FDA panel backs atezolizumab for mTNBC – at least for nowApril 28, 2021Breast CancerMetastatic Breast Cancer
Psoriasis associated with an increased risk of COVID-19 in real-world studyApril 28, 2021COVID-19 Updates
FDA approves loncastuximab for diffuse large B-cell lymphomasApril 27, 2021Lymphoma & Plasma Cell Disorders
Is it time for universal genetic testing in colorectal cancer?April 26, 2021Gastrointestinal CancerGastroenterology
Percentage of doctors who are Black barely changed in 120 yearsApril 23, 2021Diversity in MedicinePractice Management
